Lorance Sarah sold $113K of ECVT

Lorance Sarah sold 8,450 shares of Ecovyst Inc. (ECVT) at $13.33 ($0.11M total) on 2026-06-02.

Original reporting
SEC EDGAR · Lorance Sarah
Published Jun 3, 2026, 8:01 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 3, 2026, 8:17 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ECVT
Bearish
medium confidence
Mentioned
$ECVT
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ECVTBearishLow
01

Why it matters

This disclosure adds a new datapoint on insider behavior for Ecovyst but does not include any new corporate action, guidance, or performance metric.

02

Market read

Traders may briefly adjust sentiment or monitor for follow-on insider activity, but there is no fundamental catalyst in the filing itself.

03

What to watch

No 10b5-1 plan is cited; without context on prior plans, tax events, or compensation timing, interpreting directionality is uncertain.

Relevance 6/10Novelty 6/10Timing: Filed June 3; sale executed June 2 (use for same-day sentiment/positioning checks).

Background

SEC Form 4 discloses insider transactions (director/officer/10%-owner) and is commonly used as a sentiment/positioning input.

Company-level read

Ticker impact

$ECVTBearishMedium confidence
Context

Director Lorance Sarah sold 8,450 Ecovyst shares in an open-market transaction disclosed via SEC Form 4 on June 2.

Expected impact

Likely limited near-term impact; any effect would be sentiment-driven and small versus earnings/fundamental catalysts.

Evidence & confidence

The filing provides a specific sale price/value and post-transaction holdings, but insider sales alone rarely drive sustained repricing without accompanying company news.

Market effects

No direct sector read-through; this is company-specific insider activity without operational/regulatory updates.

None indicated.

None indicated.

Counterpoint

The sale could be for diversification or personal liquidity needs and does not necessarily reflect a bearish view on fundamentals.

Key entities

  • Ecovyst Inc.

    Subject of the insider transaction disclosure; director Lorance Sarah sold shares on June 2.

  • Lorance Sarah

    Director who executed the open-market sale and reported holdings after the transaction.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ECVTMed

Ecovyst names David Bradley interim CEO, Bitting to depart

Ecovyst Inc. (NYSE:ECVT) appointed David A. Bradley as interim CEO, replacing Kurt J. Bitting. Bradley, a chemical industry veteran, will lead while the board searches for a permanent CEO. Bitting will consult until February 2027. Ecovyst reaffirmed its Q4 and 2026 financial guidance. The company produces sulfuric acid and related derivatives for industrial and mining applications.

$ECVTMed

Ecovyst Inc (ECVT) (Q3 2026) Earnings Call Highlights: Raised Guidance

Ecovyst Inc. (ECVT) raised its 2026 guidance, with sales expected at $1.05B-$1.07B and adjusted EBITDA at $208M-$212M. CEO Kurt Bidding highlighted strong demand for virgin sulfuric acid, pricing power, and the Calabrian acquisition's contribution. CFO Lori Bergman noted cash flow generation and measured capital allocation. Q3 adjusted EBITDA was $61M, up 6% YoY.

$ECVTHigh

Why Ecovyst Stock Topped the Market Today

Ecovyst (NYSE:ECVT) shares rose over 2% after the company reported Q3 results. Revenue was $309M, up 51% YoY, and adjusted net income increased 18% to $25M. The company beat analyst estimates and raised full-year EBITDA guidance to $208M-$212M, citing strong demand and refinery utilization.

$ECVTMed

Ecovyst (ECVT) Q3 2026 Earnings Call Transcript

Ecovyst (ECVT) reported Q3 2026 sales of $309M, up 51% YoY, driven by higher volumes and favorable pricing. Adjusted EBITDA rose 6% to $61M. The company raised full-year sales guidance to $1.05B-$1.07B and adjusted EBITDA guidance to $208M-$212M, citing strong demand and pricing. Sulfur costs and inflation impacted margins, but cash flow remained positive.